Results 231 to 240 of about 17,908 (262)

Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor

European Journal of Cancer, 2016
Mario Lacouture, Viswanath Reddy Belum, M A Postow   +2 more
exaly  

Dermatological Agents

2018
openaire   +1 more source

Beyond the dose‐limiting toxicity period: Dermatologic adverse events of patients on phase 1 trials of the Cancer Therapeutics Evaluation Program

Cancer, 2016
Alexander Drilon, David Hyman, Mario Lacouture   +2 more
exaly  

Dermatological Agents

1964
openaire   +1 more source

Current Advances in the Prevention, Risk, and Management of Infection in Patients Receiving Biologic Therapy for Dermatologic Disorders

Current Dermatology Reports, 2019
Dennis Paul West, Beatrice Nardone, Yasmeen Ali   +2 more
exaly  

Dermatologic side effects associated with the MEK 1/2 inhibitor selumetinib (AZD6244, ARRY-142886)

Investigational New Drugs, 2010
Mario Lacouture, Klaus Busam, Paul Chapman   +2 more
exaly  

Common Applications of Dermatologic Sonography

Journal of Ultrasound in Medicine, 2012
Ximena Wortsman
exaly  

Immunobiologic Agents in Dermatology

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2007
openaire   +1 more source

Systemic Anticancer Agents

2021
exaly  

Management of antithrombotic agents in dermatologic surgery before and after publication of the corresponding German evidence‐based guideline

JDDG - Journal of the German Society of Dermatology, 2018
Matthew Gaskins, Lisa Eisert, Martin Dittmann   +2 more
exaly